Maple Grove. Minn.-based Francis Medical has announced that Aaron Milbank, MD, performed the first commercial procedure in the Midwest using its Vanquish Water Vapor Ablation System at High Pointe ...
A new randomized clinical trial found that men with localized, intermediate‑risk prostate cancer recovered faster and ...
A new randomized clinical trial found that men with localized, intermediate‑risk prostate cancer recovered faster and ...
A new randomized clinical trial found that men with localized, intermediate‑risk prostate cancer recovered faster and ...
The Society of Interventional Radiology (SIR) announced that the CAPTAIN randomized clinical trial found that men with ...
Health and Me on MSN
What every Indian man should know about prostate cancer
Prostate cancer is the most common type of slow-growing cancer in men, which, if detected early, is curable. Some early-stage symptoms of the disease are blood in the urine or semen, trouble urinating ...
The CAPTAIN trial compared the MRI-Guided TULSA Procedure™ to robotic radical prostatectomy for localized prostate cancer.
Focal therapy (FT) represents a minimally invasive option for selected patients with localized prostate cancer (PCa), aiming to achieve oncological control while preserving functional outcomes.
TORONTO, April 01, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, ...
Detailed price information for Profound Medical Corp (PROF-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results